Management of Low-Risk Papillary Thyroid Cancer
- PMID: 29947175
- PMCID: PMC6021317
- DOI: 10.3803/EnM.2018.33.2.185
Management of Low-Risk Papillary Thyroid Cancer
Abstract
The incidence of thyroid cancer has increased, mainly due to the incidental finding of low-risk papillary thyroid cancers (PTC). These malignancies grow slowly, and are unlikely to cause morbidity and mortality. New understanding about the prognosis of tumor features has led to reclassification of many tumors within the low-risk thyroid category, and to the development of a new one "very low-risk tumors." Alternative less aggressive approaches to therapy are now available including active surveillance and minimally invasive interventions. In this narrative review, we have summarized the available evidence for the management of low-risk PTC.
Keywords: Active surveillance; Carcinoma, papillary; Ethanol injection; Low-risk; Micropapillary.
Copyright © 2018 Korean Endocrine Society.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
References
-
- Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140:317–322. - PubMed
-
- Vaccarella S, Dal Maso L, Laversanne M, Bray F, Plummer M, Franceschi S. The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries. Thyroid. 2015;25:1127–1136. - PubMed
-
- Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016;375:614–617. - PubMed
-
- Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest. 2009;39:699–706. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
